Targeting epicardial adipose tissue in heart failure with preserved ejection fraction: exploring the dapagliflozin connection
Abstract Background Heart failure with preserved ejection fraction is the fastest-growing subtype of heart failure, especially among the elderly. Aim It is aimed to determine whether the addition of 10 mg of Dapagliflozin for HFpEF patient can lead to a decrease in epicardial adipose tissue volume....
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2026-04-01
|
| シリーズ: | BMC Cardiovascular Disorders |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1186/s12872-026-05819-4 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|